Print PDF

Practice Areas

Additional Time for Input on Reducing FDA’s Regulatory Burden

Wednesday, December 06, 2017
Sandler, Travis & Rosenberg Trade Report

The Food and Drug Administration is extending until Feb. 5 the deadline for interested parties to submit comments and information to help the agency identify existing regulations and related paperwork requirements that could be modified, repealed, or replaced, consistent with U.S. law, to achieve meaningful burden reduction while allowing the FDA to achieve its public health mission and fulfill statutory obligations. Initially published on Sept. 8, the request for input involves the FDA’s general regulatory and information collection requirements as well as regulatory and information requirements by six product-oriented centers that carry out the agency’s mission.

To get news like this in your inbox daily, subscribe to the Sandler, Travis & Rosenberg Trade Report.

Customs & International Headlines